The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity

被引:25
作者
Argyris, EG
Kulkosky, J
Meyer, ME
Xu, Y
Mukhtar, M
Pomerantz, RJ
Williams, KJ
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med,Ctr Human Virol & Biodef, Div Infect Dis & Environm Med,Dorrance H Hamilton, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Div Endocrinol Diabet & Metab Dis,Dept Med, Dorrance H Hamilton Labs,Ctr Human Virol & Biodef, Philadelphia, PA 19107 USA
关键词
human immunodeficiency virus type 1; Tat; heparan sulfate proteoglycans; long terminal repeat;
D O I
10.1016/j.virol.2004.10.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cell surface heparan sulfate proteoglycans (HSPGs) mediate internalization of HIV-1 Tat. Herein, we report that human WiDr cells, which express perlecan but no other HSPGs, can internalize I-125-labeled Tat with minimal lysosomal degradation. Pre-treatment of cells with heparitinase almost completely abolished I-125-Tat surface binding, while the use of an HIV-1 long terminal repeat (LTR) promoter-reporter construct demonstrated that transactivation was potently blocked by pretreatment of cells with heparitinase, indicating an essential role for perlecan in the biologic effects of Tat. We conclude that the perlecan mediates Tat uptake and is required for HIV-1 LTR-directed transactivation in this human cell type. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:481 / 486
页数:6
相关论文
共 21 条
[1]   Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells [J].
Acheampong, E ;
Mukhtar, M ;
Parveen, Z ;
Ngoubilly, N ;
Ahmad, N ;
Patel, C ;
Pomerantz, RJ .
VIROLOGY, 2002, 304 (02) :222-234
[2]   Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts [J].
Argyris, EG ;
Acheampong, E ;
Nunnari, G ;
Mukhtar, M ;
Williams, KJ ;
Pomerantz, RJ .
JOURNAL OF VIROLOGY, 2003, 77 (22) :12140-12151
[3]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[4]  
DODGE GR, 1990, J BIOL CHEM, V265, P18023
[5]   RELEASE, UPTAKE, AND EFFECTS OF EXTRACELLULAR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN ON CELL-GROWTH AND VIRAL TRANSACTIVATION [J].
ENSOLI, B ;
BUONAGURO, L ;
BARILLARI, G ;
FIORELLI, V ;
GENDELMAN, R ;
MORGAN, RA ;
WINGFIELD, P ;
GALLO, RC .
JOURNAL OF VIROLOGY, 1993, 67 (01) :277-287
[6]   Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time [J].
Ferrari, A ;
Pellegrini, V ;
Arcangeli, C ;
Fittipaldi, A ;
Giacca, M ;
Beltram, F .
MOLECULAR THERAPY, 2003, 8 (02) :284-294
[7]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193
[8]   HIV-1: Fifteen proteins and an RNA [J].
Frankel, AD ;
Young, JAT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :1-25
[9]   Perlecan heparan sulfate proteoglycan - A novel receptor that mediates a distinct pathway for ligand catabolism [J].
Fuki, IV ;
Iozzo, RV ;
Williams, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25742-25750
[10]   The syndecan family of proteoglycans - Novel receptors mediating internalization of atherogenic lipoproteins in vitro [J].
Fuki, IV ;
Kuhn, KM ;
Lomazov, IR ;
Rothman, VL ;
Tuszynski, GP ;
Iozzo, RV ;
Swenson, TL ;
Fisher, EA ;
Williams, KJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1611-1622